Status:
NOT_YET_RECRUITING
Observation of Clinical Effect of New Oropharyngeal Airway in Patients With OSHAS During Painless Gastroenteroscopy
Lead Sponsor:
Jianbo Wu
Conditions:
OSAHS
Gastrointestinal Endoscopy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
the(obstructivesleepapneahypoapneasyndromeOSAHS) is a kind of to sleep appear periodically in the process of syndrome characterized by partial or complete obstruction of upper respiratory tract.Patien...
Detailed Description
1\. The study population was recruited by the principal investigator under strict control, and 130 patients with obstructive sleep apnea hypopnea syndrome (diagnosed as OSAHS by polysomnography monito...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age 18-65 years old
- evidence of polysleep monitoring for diagnosis of OSAHS
- written informed consent of patient or family member
- painless stomach + colonoscopy
- ASA grade I-II
- Exclusion criteria:
- Patients with clotting disorders or a tendency to oropharyngeal bleeding, mucosal damage or space occupation, difficulty in placing oropharyngeal airway, etc., who could not perform oropharyngeal airway ventilation;
- Upper respiratory tract infections such as mouth, nose or throat;
- Fever (core body temperature ≥37.5℃);
- a confirmed diagnosis of pregnancy or breastfeeding;
- Allergic to sedatives such as propofol or equipment such as tape;
- Emergency surgery;
- Multiple trauma;
- SpO2 \< 95% before operation;
- A history of drug and/or alcohol abuse within 2 years prior to the start of the screening period;(Drinking more than three times standard alcoholic beverages per day, equivalent to about 10g of alcohol or equivalent to 50g of Chinese liquor);
- Patients with previous psychiatric and neurological diseases, such as depression, severe central nervous depression, Parkinson's disease, basal ganglia disease, schizophrenia, epilepsy, Alzheimer's disease, myasthenia gravis;
- Currently participating in other clinical trials;
- Patients who are deemed unfit by the investigator to participate in the trial;
- Patients with a history of smoking should not participate in this study.
Exclusion
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06594380
Start Date
October 1 2024
End Date
December 1 2025
Last Update
September 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.